Clinical Trials

Elderly Metastatic Colorectal Cancer Patients

NCT02688712 2026-04-13

ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

50 enrolled

Rectal Neoplasms

NCT06417476 2026-04-13

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

66 enrolled

Rectal Neoplasms

NCT03764553 2026-04-07

LyRICX

320 enrolled

Esophageal Neoplasms

NCT04245865 2026-04-03

Toco-CoR

83 enrolled

Phase EARLY_PHASE1 Active not recruiting

Colorectal Neoplasms

NCT05108428 2026-04-01

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

20 enrolled

Phase 1/2 Active not recruiting

Colonic Neoplasms, Rectal Neoplasms

NCT03585465 2026-03-18

Metro-PD1

63 enrolled

Other solid neoplasm

Childhood Solid Tumor

NCT01918527 2026-03-10

Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer

250 enrolled

Colonic Neoplasms

NCT05171660 2026-02-17

Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer

446 enrolled

Colorectal Neoplasms

NCT03399110 2026-01-27

XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

1,024 enrolled

Stomach Neoplasms

NCT05807880 2026-01-23

ALTER-HN005

59 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT03257163 2026-01-20

Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer

40 enrolled

Phase 1 Active not recruiting

Stomach Neoplasms

NCT04523818 2026-01-14

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

25 enrolled

Clinical Stage I Gastric Cancer AJCC v8

NCT04539808 2026-01-14

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

42 enrolled 13 charts

Pancreatic Adenocarcinoma

NCT05826964 2026-01-13

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

24 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT04564898 2026-01-08

TriComB

48 enrolled

Colorectal Cancer Metastatic

NCT03921684 2026-01-05

Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients

29 enrolled

Phase 2/3 Active not recruiting

Rectal Neoplasms

NCT05902533 2025-12-18

REDEL

33 enrolled

Anus Neoplasms

NCT04595565 2025-11-25

SASCIA

1,332 enrolled

Triple Negative Breast Neoplasms

NCT07248670 2025-11-25

Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC

252 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01941641 2025-11-17

Colon Neoadjuvant FOLFOXIRI Study

40 enrolled

Rectal Neoplasms

NCT06281886 2025-11-17

Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma

170 enrolled

Esophageal Squamous Cell Carcinoma

NCT01972919 2025-10-27

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

23 enrolled 8 charts

Pancreatic Neoplasms

NCT04443348 2025-10-14

Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

120 enrolled

Triple Negative Breast Neoplasms

NCT07215936 2025-10-14

Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

100 enrolled

Colorectal Neoplasms

NCT02505750 2025-09-29

OPERA

148 enrolled

Rectal Neoplasms

NCT06124378 2025-09-24

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

60 enrolled

Colonic Neoplasms

NCT04158362 2025-09-22

AMBRE

180 enrolled

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT01061515 2025-09-17

Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer

21 enrolled

Tumor-Agnostic

Carcinoma

NCT04335669 2025-09-12

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

325 enrolled

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05063786 2025-09-08

ALPHABET

27 enrolled

Breast Neoplasms

NCT05610163 2025-09-08

JANUS

783 enrolled

Phase 1/2 Active not recruiting

Rectal Neoplasms

NCT05990543 2025-09-08

Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer

59 enrolled

Recurrence, Colorectal Neoplasms

NCT02008656 2025-08-27

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

358 enrolled

Phase 1 Active not recruiting

Rectal Neoplasms

NCT04046133 2025-08-05

CORINTH

52 enrolled

Anus Neoplasms

NCT03828227 2025-07-18

COLAGE

49 enrolled

Colorectal Neoplasms

NCT02678182 2025-06-10

PLATFORM

494 enrolled

Adenocarcinoma of the Oesophagus

NCT03448835 2025-06-08

PANDA

20 enrolled

Stomach Neoplasms

NCT03073785 2025-05-25

Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer

46 enrolled

Pancreatic Neoplasms

NCT04198727 2025-05-23

DPDMAX

155 enrolled

Breast Neoplasm Malignant Female

NCT06975917 2025-05-16

TOG-SAFRADJU

Active not recruiting

600 enrolled

Phase 2/3 Active not recruiting

Biliary Tract Neoplasms

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

635 enrolled 9 charts

Colonic Neoplasms

NCT03523312 2025-05-02

MAIBE

47 enrolled

Pancreatic Neoplasms

NCT04296162 2025-04-17

ORCHID

178 enrolled

Breast Neoplasms

NCT04517214 2025-04-02

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

100 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05247905 2025-04-02

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors

31 enrolled

Adenoma, Islet Cell

NCT06056804 2025-04-02

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

20 enrolled

Locally Advanced Rectal Cancer

NCT02170090 2025-03-30

ACTICCA-1

789 enrolled

Phase 2/3 Active not recruiting

Gallbladder Neoplasms, Cholangiocarcinoma

NCT02945566 2025-03-27

STAR-TREC

380 enrolled